
Keywords: ATN1; atrophin-1; CNS; central nervous system; DRPLA; dentatorubral-pallidoluysian atrophy; HD; Huntington's disease; polyQ; polyglutamine; polyL; polyleucine; SCA; spinocerebellar ataxia; TPEN; N,N,Nâ²,Nâ²-tetrakis (2-pyridylmethyl) ethylenediamine; Z-